Tuberculosis test cartridges recalled after failing expected stability criteria
Cepheid is recalling 9,880 Xpert MTB/RIF cartridges from one lot because product testing did not meet expected stability criteria.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: Scored 2 because the record cites a stability specification failure without describing an erroneous result or any reported harm.
Plain-English summary
The Cepheid Xpert MTB/RIF, model GXMTB/RIF-US-10, is being recalled.
Product testing did not meet expected stability criteria.
The recall covers 9,880 units carrying UDI-DI 07332940000912, from batch 1000812229, lot 41302. The product was distributed nationwide in the United States and in Puerto Rico. The FDA has classified the action as Class II.
The enforcement record states the stability failure without describing a testing consequence or reporting injuries. Laboratories holding the affected lot should follow Cepheid's instructions.
The recalled product
- Product
- Xpert MTB/RIF. Model Number: GXMTB/RIF-US-10.
- Manufacturer
- Cepheid
- Category
- Medical Device — Diagnostic test
- Affected units
- 9,880
Distribution
Related recalls
Same manufacturer · Cepheid
See all →- HighLeukemia test kits recalled over inaccurate results with high white cell counts
FDA (Devices) · 2025-12-24
- HighLeukemia test kits recalled in a second lot family over inaccurate results
FDA (Devices) · 2025-12-24
- HighNasal test kits recalled after a false negative on a positive sample
FDA (Devices) · 2025-11-05
- HighCepheid Sample Collection Device May Leak Causing Cross-Contamination Risk
FDA (Devices) · 2024-08-21
- HighCepheid Xpert Xpress Strep A test kits may produce invalid results
FDA (Devices) · 2023-11-08
Same hazard · stability failure
See all →- ModerateApotex Recalls Paxil Tablets for Failed Dissolution and Stability Testing
FDA (Drugs) · 2026-09-02
- ModerateVasocaine lidocaine spray recalled because stability data does not support expiry
FDA (Drugs) · 2026-03-11
- ModerateZone 1 lidocaine cream recalled because stability data does not support expiry
FDA (Drugs) · 2026-03-11
- ModerateZone 2 lidocaine cream recalled because stability data does not support expiry
FDA (Drugs) · 2026-03-11
- ModerateCisatracurium 20 mg multiple-dose vials recalled after subpotent assay results
FDA (Drugs) · 2025-12-24